StarZero All shows Try the podcast clipper →

Royalty Pharma

2 statements across 2 episodes · 2 bullish · 0 bearish · 1 people on the record · first statement Jan 20, 2023 by Chamath Palihapitiya · said 5 times in 4 episodes since 2022 · across every show →

Mentions by year

brought up most by Chamath Palihapitiya (4), David Friedberg (1)

tap a year for its mentions
002132202220232024episodesmentions
012202220232024episodes it came up in
000.811.52202220232024episodesmentions per episode
2024 3 mentions in 2 episodes 2 per episode
2023 1 mention in 1 episode
2022 1 mention in 1 episode

every mention, scene by scene, with the transcript →

Everything said about Royalty Pharma, oldest first

Jan 20, 2023 bullish
Assertion Supported
Chamath: Royalty Pharma has a $22.5B valuation and 90% EBITDA margins
“The best performing company in pharma is a company called Royalty Pharma. It's a 22 and a half billion dollar company that has 90% EBITDA margins.”
Chamath Palihapitiya Jan 20, 2023 ▶ 1:27:15 E112: Is Davos a grift? Plus: globalist mishaps, debt ceilings, TikTok's endgame & more
May 17, 2024 bullish
Prediction Open · timeframe May 2027
Chamath: Isomorphic Labs will reach Royalty Pharma margins at 10x-100x revenue
“I think something like isomorphic ends up being of that magnitude of margin scale, but at an order of magnitude or two orders of magnitude higher revenue.”
Chamath Palihapitiya May 17, 2024 ▶ 1:25:23 GPT-4o launches, Glue demo, Ohalo breakthrough, Druck's Argentina bet, did Google kill Perplexity?
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 460 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more